ChronoScale CHRN 深 滬
等待開盤 10-08 09:30:00 美东时间
19.77
+0.490
+2.54%
華盛通- 最 高20.15
- 今 開18.44
- 成交量 12.35万股
- 最 低 18.44
- 昨 收 19.28
- 總市值 28.79亿
- 52周最高 30.00
- 市盈率 靜 --
- 換手率 0.08%
- 52周最低 3.50
- 委 比 35.17%
- 總股本 1.46亿
- 歷史最高 1073.25
- 量 比 1.12
- 振 幅 8.87%
- 歷史最低 3.4635
- 每 手 1
- 風險率 6.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ChronoScale Director Resigns Following Ekso Bionics Divestiture
ChronoScale ( ($CHRN) ) has issued an announcement. ChronoScale Holdings Corpor...
10-07 05:51
ChronoScale expands AI infrastructure contracts, refines growth focus
ChronoScale ( ($CHRN) ) has shared an announcement. ChronoScale completed the s...
10-03 05:48
At a glance: Stocks gapping up premarket
Here's a quick look at the stocks that are seeing gap-up moves before the bell on Friday. Stock index futures rose before the bell as investors braced for the September nonfarm payrolls report, with e...
10-02 20:31
ChronoScale Signs Contract Extension And New Agreement With AI Infrastructure Customers; Agreements Provide For $1B Annualized Run-rate Revenue By Q3 2027
Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracted deployment pipeline and is expected to drive Company annualized revenue run rate to $1 billion by calendar Q3 2027 ChronoScale completes previously disclosed sale of Ekso Bionics business u...
10-02 05:42
ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit
ChronoScale Holdings Corporation has expanded an existing AI infrastructure customer agreement and signed a new customer contract, increasing its contracted deployment pipeline and aiming for $1 billion in annualized revenue by Q3 2027. The company has also completed the sale of its Ekso Bionics business unit, allowing it to focus on its core AI infrastructure business.
10-01 21:40
美股大行评级 | 奈飞遭看淡至57美元！现价仍有两成下行空间；Xenon制药遭多家机构降目标价，最低看至46美元
今日重点评级关注：康托·菲茨杰拉德：维持Abeona Therapeutics"超配"评级，目标价从28美元升至30美元；HC Wainwright & Co.：维持Oculis Holding"买入"评级，目标价从26美元升至39美元
09-21 16:25
Northland Capital Markets Initiates Coverage On ChronoScale Holdings with Outperform Rating, Announces Price Target of $32
Northland Capital Markets analyst Nehal Chokshi initiates coverage on ChronoScale Holdings (NASDAQ:CHRN) with a Outperform rating and announces Price Target of $32.
09-19 01:19
ChronoScale amends term loan, extends debt maturity
ChronoScale ( ($CHRN) ) has issued an announcement. On September 12, 2026, Chro...
09-17 05:29
Nutanix Recognized as a Leader in the Gartner® Distributed Hybrid Infrastructure Magic Quadrant™
Nutanix has been recognized as a Leader in the 2026 Gartner Magic Quadrant for Distributed Hybrid Infrastructure, acknowledged for its ability to execute and completeness of vision. The company's Nutanix Cloud Platform (NCP) provides a unified platform for running AI workloads, applications, and data across on-premises, cloud, and edge environments. Over the past year, Nutanix has expanded NCP with new capabilities for agentic AI, advanced Kubern...
09-10 15:00
美股周涨跌榜 | 绩优股周内集体飙升！爱芬奇劲升36%，Okta升23%，赛富时升逾22%
绩优股周内集体飙升！爱芬奇劲升36%，Okta升23%，赛富时升逾22%；RZLV升逾20%，与谷歌达成数据库技术合作>>
08-29 10:29
